Aarti Drugs Ltd.

•

aartidrugs.comBSE: 524348NSE: AARTIDRUGS

Market Cap₹ 3,910 Cr.

Current Price

High / Low₹ 535 / 319

Stock P/E20.4

Book Value₹ 175

Price to Book2.27

Dividend Yield0.47 %

ROCE13.1 %

ROE12.7 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has consistently been profitable over the last 5 years
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.46x)
Company generates healthy free cash flow
Company has a consistent dividend-paying track record
Company comfortably covers its interest (6.4x coverage)
Company maintains a comfortable, low leverage position

CONS

Recent results are weak - TTM profit is down 18.2% versus prior year
Company has delivered a poor profit growth of 3.5% over past five years
Company has delivered a poor sales growth of 5.7% over past five years
Though reporting repeated profits, the company pays out little dividend (5.4%)
Growth is decelerating - 3Y profit CAGR (-6.4%) trails the 5Y trend (3.5%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY MICROCAP250 NIFTY TOTAL MKT

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	AARTIDRUGS	428.35	20.45	3909.55	0.47	50.13	-7.12	702.78	19.01	13.11	13.97

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	661	642	606	620	555	598	557	677	591	653	602	720	703
	577	565	536	534	490	531	495	583	516	569	547	624	632
Operating Profit	84	76	70	86	65	67	62	93	74	84	55	96	71
OPM %	12.72%	11.92%	11.58%	13.84%	11.70%	11.21%	11.09%	13.79%	12.55%	12.91%	9.15%	13.30%	10.03%
	1	1	2	1	1	1	12	2	0	0	1	1	3
Interest	9	8	8	9	9	9	9	9	9	8	9	8	9
Depreciation	13	13	13	14	13	14	14	15	15	16	18	18	18
Profit before Tax	64	56	52	64	44	46	51	71	51	60	29	70	69
Tax %	24.49%	29.63%	28.79%	26.29%	24.35%	23.80%	26.93%	11.78%	-5.60%	25.24%	-39.68%	21.46%	27.60%
Net Profit	0	0	0	0	33	35	37	63	54	45	41	55	50
	5.18	4.29	3.99	5.15	3.62	3.83	4.06	6.88	5.91	4.95	4.44	6.05	5.49

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	1,140	1,195	1,244	1,561	1,806	2,155	2,489	2,716	2,529	2,387	2,678
	960	1,005	1,042	1,350	1,541	1,714	2,156	2,407	2,208	2,097	2,372
Operating Profit	180	190	202	211	266	440	333	309	321	290	306
OPM %	15.78%	15.94%	16.23%	13.51%	14.70%	20.44%	13.36%	11.39%	12.69%	12.16%	11.41%
	0	4	1	6	6	5	11	2	4	16	5
Interest	48	40	38	44	37	26	24	37	38	39	34
Depreciation	37	38	40	43	49	50	50	50	51	56	71
Profit before Tax	95	116	125	131	185	369	270	224	236	212	229
Tax %	27.87%	29.49%	33.89%	31.50%	23.69%	24.01%	24.06%	25.79%	27.15%	20.62%	16.56%
Net Profit	69	82	82	90	141	280	205	166	172	168	191
EPS	28.38	33.46	34.41	38.48	15.14	30.09	22.12	17.97	18.65	18.42	—
Dividend Payout %	23.79%	2.92%	2.87%	2.63%	3.30%	8.31%	4.52%	5.57%	5.36%	5.43%	—

COMPOUNDED SALES GROWTH

10 Years:: 8%
5 Years:: 6%
3 Years:: -1%

COMPOUNDED PROFIT GROWTH

10 Years:: 8%
5 Years:: 4%
3 Years:: -6%

STOCK PRICE CAGR

10 Years:: 14%
5 Years:: -7%
3 Years:: -10%
1 Year:: -16%

RETURN ON EQUITY

10 Years:: 20%
5 Years:: 20%
3 Years:: 14%
Last Year:: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	24	24	24	24	23	93	93	93	92	91
	333	376	432	520	629	820	944	1,100	1,190	1,278
	460	494	558	518	394	316	550	762	491	558
Trade Payables	185	197	259	243	330	330	469	480	425	416
	100	100	117	151	200	207	153	-13	234	232
Total Liabilities	1,102	1,191	1,389	1,455	1,577	1,766	2,208	2,421	2,432	2,575
	493	581	602	625	644	665	690	676	811	866
Capital Work in Progress	34	14	28	33	12	19	77	187	225	274
	5	12	11	12	13	17	19	19	20	22
	178	210	278	247	325	415	526	516	486	473
	0	0	0	0	0	0	0	0	705	751
Cash & Bank	5	4	4	6	8	10	22	9	9	8
	387	370	465	533	574	639	874	1,014	176	180
Total Assets	1,102	1,191	1,389	1,455	1,577	1,766	2,208	2,421	2,432	2,575

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	153	196	94	173	292	252	154	193	359	245
Cash from Investing	-99	-107	-74	-62	-33	-72	-150	-164	-224	-165
Cash from Financing	-33	-68	4	-80	-215	-81	92	17	-136	-82
	1	-0	0	1	2	2	13	-14	-1	-2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	55.67	55.64	55.38	55.48	55.22	54.72	55.03	55.03	54.43
	2.95	2.50	2.28	2.25	2.26	2.68	2.15	1.57	1.52
	7.35	7.83	8.77	9.70	9.94	9.90	10.12	10.22	10.29
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	34.02	34.02	33.57	32.57	32.58	32.69	32.70	33.18	33.75

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-03

Copy of Newspaper Publication

2026-09-03 - Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-02

Updates

2026-09-02 - Aarti Drugs Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for FY 2025-26 '.

2026-09-02

Shareholders meeting

2026-09-02 - Aarti Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2026

2026-09-01

Copy of Newspaper Publication

2026-09-01 - Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-27

Outcome of Board Meeting

2026-08-27 - Aarti Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2026.

2026-08-24

Trading Window

2026-08-24 - Aarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

2026-08-14

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-14 - Aarti Drugs Limited has informed the Exchange about Schedule of meet

2026-08-10

Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-10 - Aarti Drugs Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-07

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-07 - Aarti Drugs Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for AARTIDRUGS

Loading news…

🤖

AI Stock Analyst

Aarti Drugs Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

AARTIDRUGS

428.35

20.45

3909.55

0.47

50.13

-7.12

702.78

19.01

13.11

13.97

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

661

642

606

620

555

598

557

677

591

653

602

720

703

577

565

536

534

490

531

495

583

516

569

547

624

632

Operating Profit

OPM %

12.72%

11.92%

11.58%

13.84%

11.70%

11.21%

11.09%

13.79%

12.55%

12.91%

9.15%

13.30%

10.03%

Interest

Depreciation

Profit before Tax

Tax %

24.49%

29.63%

28.79%

26.29%

24.35%

23.80%

26.93%

11.78%

-5.60%

25.24%

-39.68%

21.46%

27.60%

Net Profit

5.18

4.29

3.99

5.15

3.62

3.83

4.06

6.88

5.91

4.95

4.44

6.05

5.49

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

1,140

1,195

1,244

1,561

1,806

2,155

2,489

2,716

2,529

2,387

2,678

960

1,005

1,042

1,350

1,541

1,714

2,156

2,407

2,208

2,097

2,372

Operating Profit

180

190

202

211

266

440

333

309

321

290

306

OPM %

15.78%

15.94%

16.23%

13.51%

14.70%

20.44%

13.36%

11.39%

12.69%

12.16%

11.41%

Interest

Depreciation

Profit before Tax

116

125

131

185

369

270

224

236

212

229

Tax %

27.87%

29.49%

33.89%

31.50%

23.69%

24.01%

24.06%

25.79%

27.15%

20.62%

16.56%

Net Profit

141

280

205

166

172

168

191

EPS

28.38

33.46

34.41

38.48

15.14

30.09

22.12

17.97

18.65

18.42

—

Dividend Payout %

23.79%

2.92%

2.87%

2.63%

3.30%

8.31%

4.52%

5.57%

5.36%

5.43%

—

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity Capital

333

376

432

520

629

820

944

1,100

1,190

1,278

460

494

558

518

394

316

550

762

491

558

Trade Payables

185

197

259

243

330

469

480

425

416

100

117

151

200

207

153

-13

234

232

Total Liabilities

1,102

1,191

1,389

1,455

1,577

1,766

2,208

2,421

2,432

2,575

493

581

602

625

644

665

690

676

811

866

Capital Work in Progress

187

225

274

178

210

278

247

325

415

526

516

486

473

705

751

Cash & Bank

387

370

465

533

574

639

874

1,014

176

180

Total Assets

1,102

1,191

1,389

1,455

1,577

1,766

2,208

2,421

2,432

2,575

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

153

196

173

292

252

154

193

359

245

Cash from Investing

-99

-107

-74

-62

-33

-72

-150

-164

-224

-165

Cash from Financing

-33

-68

-80

-215

-81

-136

-82

-0

-14

-1

-2

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

55.67

55.64

55.38

55.48

55.22

54.72

55.03

54.43

2.95

2.50

2.28

2.25

2.26

2.68

2.15

1.57

1.52

7.35

7.83

8.77

9.70

9.94

9.90

10.12

10.22

10.29

Government

0.00

34.02

33.57

32.57

32.58

32.69

32.70

33.18

33.75

Aarti Drugs Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Aarti Drugs Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI